Characteristics of studies included in meta-analysis of association of chocolate consumption with risk of cardiometabolic disorders
| Study (setting) | Intervention measures | Study design | Quality score* | Participants | Follow-up (years) | Outcome measures | |
|---|---|---|---|---|---|---|---|
| No in analysis | Characteristics | ||||||
| Oba et al 201016 (Japan) | Consumption of coffee, tea, chocolate snacks, and caffeine content | Cohort | 5 | 13 540 | Asian men and women | 10 | Incidence of diabetes |
| Mink et al 200714 (USA) | Flavonoid intake | Cohort | 5 | 34 489 | White postmenopausal women | 16 | Coronary heart disease, stroke, cardiovascular mortality |
| Janszky et al 200913 (Sweden) | Chocolate consumption | Cohort | 4 | 1169 | White men and women who had had an acute myocardial infarction | 8 | Cardiovascular mortality, recurrent myocardial infarction, stroke, congestive heart failure |
| Buijsse et al 20067 (Netherlands) | Cocoa intake | Cohort | 5 | 470 | White men | 15 | Blood pressure, cardiovascular mortality |
| Mostofsky et al 201015 (Sweden) | Chocolate intake | Cohort | 5 | 31 823 | Middle aged and elderly white women | 9 | Incidence of heart failure |
| Buijsse et al 20109 (Germany) | Chocolate consumption | Cohort | 5 | 19 357 | White men and women | 10 | Blood pressure, myocardial infarction, incident cardiovascular disease, stroke |
| Djousse et al 201010 (USA) | Chocolate consumption | Cross sectional | 5 | 4970 | Men and women of mixed ethnicity | NA | Coronary heart disease |
*Score 0-6, with 6 representing high quality.